Veraxa-News-December
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline Zurich, 29th of December 2023: VERAXA Biotech AG, a pioneering company in the development of
August 8, 2024
No Comments
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline Zurich, 29th of December 2023: VERAXA Biotech AG, a pioneering company in the development of
Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for
Collaboration of Xlife Sciences and the Department of Health – Abu Dhabi to drive global innovations in the life sciences sector Abu Dhabi, United Arab
Are you interested in getting in touch with us? We would be happy to support you in your plans
SGIP is a member of the Financial Services Ombudsman’s Office (OFD) since May 2021.
Copyright © 2024. Swiss Gulf Investment Partners. All Rights Reserved.